Conquering the Challenge of Drug-Resistant Bacteria! Salvianic acid becomes a new natural material against Helicobacter pylori

In 2026, the global field of natural antibacterial scientific research welcomed a major breakthrough. Addressing the clinical challenge of treating drug-resistant bacterial infections a domestic university research team has achieved substantial results. A research team from Hainan Medical University published a specialized research paper in the top international journal Advanced Science, systematically confirming that salv acid—a natural fat-soluble active monomer derived from rosemary—possesses potent, broad-spectrum, and non-resistant antibacterial activity against multidrug-resistant Helicobacter This study successfully breaks through the technical bottlenecks of traditional antibiotic treatment for H. pylori*, solving industry pain points such as drug resistance, microbiota imbalance, and severe side effects in treatment. It provides a brand-new, purely natural solution for universal gastric health care and auxiliary treatment of drug-resistant bacterial infections, filling the market gap for high-end natural plant extracts and injecting new momentum into the innovation and upgrading of the gastrointestinal health industry. Helicobacter pylori is currently recognized as the core pathogenic bacterium inducing various gastrointestinal such as chronic gastritis, gastric ulcers, duodenal ulcers, and reflux esophagitis. Long-term continuous infection also significantly increases the risk of gastric lesions, making it the threat to national gastrointestinal health. According to domestic gastrointestinal health survey data, the infection rate of H. pylori in China has long remained high, with more than half the population suffering from varying degrees of infection, and the trend of infection among younger people is becoming increasingly obvious. In traditional clinical treatment, triple and quadruple antibiotic therapies are the mainstream treatment regimens but long-term clinical application has exposed many drawbacks. The abuse and repeated use of antibiotics have led to a large number of H. pylori strains developing multidrug resistance, causing treatment success rate to decline annually and the recurrence rate to continue climbing. Meanwhile, antibiotics indiscriminately kill intestinal microbiota, easily causing the loss of beneficial intestinal bacteria and imbalance of the intestinal microecology, secondary problems such as diarrhea, abdominal bloating, indigestion, and decreased immunity, which cause secondary damage to human gastrointestinal health. There is an urgent clinical need for new natural antibacterial substances are highly efficient and safe, do not easily develop resistance, and can precisely inhibit bacteria. This specialized study comprehensively elucidates the multiple mechanisms of action of salvianic acid against drug- H. pylori. Distinguishing itself from the single bactericidal mode of antibiotics, salvianic acid can achieve precise bacterial inhibition and killing through multi-target synergistic effects. First, can efficiently inhibit the exclusive urease activity of H. pylori, blocking the energy source for the pathogen's survival and reproduction, thereby inhibiting pathogen proliferation at its source; second it can precisely destroy the biofilm that H. pylori relies on for survival, breaking through the pathogen's drug-resistant protective barrier and causing the pathogen to lose its survival carrier third, it can directly damage the pathogen's cell membrane structure, destroying cell integrity and rapidly killing drug-resistant strains; fourth, it can weaken the pathogen's motility and colonization, preventing the pathogen from attaching and reproducing on the gastric mucosa, effectively reducing the infection recurrence rate. Numerous control experiments have confirmed that, compared to traditional antibiotic therapy, the maximum advantages of salvianic acid are no drug resistance, precise bacterial inhibition, and protection of intestinal microbiota. Long-term use will not induce strain resistance, and it only targets harmful bacteria without damaging the beneficial intestinal microbiota of the human body, perfectly solving the core drawbacks of traditional treatment regimens. Its safety and compatibility far exceed those of artificial antibacterial ingredients

In vivo experimental data from animal models further validate the application value of rosmarinic acid. In the highly acidic environment of the human stomach,marinic acid maintains exceptional structural stability, providing long-lasting and highly effective antibacterial activity without being corroded or decomposed by gastric acid. It can continuously act on the gastric mucosal area, with an intervention effect on multidrug-resistant Helicobacter pylori infection significantly superior to conventional antibiotic therapies. With the diversification of national dietary structures, the normalization of food delivery, irregular eating habits, sub-health issues related to the public's gastrointestinal health have become increasingly prevalent, leading to a continuous surge in demand for Helicobacter pylori prevention and daily gastrointestinal. Currently, high-purity rosmarinic acid has gradually achieved industrial application, being widely used in terminal product categories such as high-end gastrointestinal care health products, functional-care foods, oral antibacterial care products, and digestive tract repair dietary supplements. Industry experts predict that under the trend of refined gastrointestinal health care for the entire population, rosinic acid—which combines multiple advantages of potent antibacterial activity, anti-inflammatory repair, safety and mildness, and no drug resistance—will continue to replace traditional synthetic antibacterial ingredients. is poised to become a core essential raw material in the gastrointestinal health sector, possessing immense market growth potential.